CoChat

The DOI matches its Crossref record; 131 of the 136 references it cites were found in a registry or an index.

Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies

Open access

Abstract

Breast cancer remains one of the most prevalent malignancies worldwide, and radiation therapy is a central component of its management. However, intrinsic or acquired resistance to radiation significantly compromises therapeutic efficacy. This systematic review aimed to identify and evaluate molecular mechanisms and interventions that influence radiation sensitivity in breast cancer models. A comprehensive PubMed search was conducted using the terms “breast cancer” and “radiation resistance” for studies published between 2002 and 2024. Seventy-nine eligible studies were included. The most frequently investigated mechanisms included the dysregulation of the PI3K/AKT/mTOR and MAPK signaling pathways, enhanced DNA damage repair via non-homologous end joining (NHEJ), and the overexpression of cancer stem cell markers such as CD44+/CD24−/low and ALDH1. Several studies highlighted the role of non-coding RNAs, particularly the lncRNA DUXAP8 and microRNAs such as miR-21, miR-144, miR-33a, and miR-634, in modulating radiation response. Components of the tumor microenvironment, including cancer-associated fibroblasts and immune regulators, also contributed to radiation resistance. By synthesizing current evidence, this review provides a consolidated resource to guide future mechanistic studies and therapeutic development. This review highlights promising molecular targets and emerging strategies to enhance radiosensitivity and offers a foundation for translational research aimed at improving outcomes in radiation-refractory breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cimb47080589

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 6 DNA double-strand break (DSB) repair mechanisms and their role in radiation resistance. (A) DSBs can be repaired through homologous recombination (HR) when a sister chromatid is available as a template, typically during the S and G2 phases of the cell cycle [52]. Alternatively, non-homologous end joining (NHEJ) directly ligates the broken DNA ends without a homologous template [52]. (B) Denticleless E3 ubiquitin protein ligase homolog (DTL) ubiquitinates RuvB-like AAA ATPase 1 (RUVBL1) to facilitate the formation of the RUVBL1/2–β-catenin complex, which transcriptionally upregulates genes involved in the NHEJ pathway, thereby enhancing DNA repair and promoting radiation resistance (C) Human antigen R (HuR), an RNA-binding protein often overexpressed in breast cancer, stabilizes AT-rich interaction domain 1A (ARID1A) mRNA, leading to increased ARID1A expression and enhanced DSB repair [39]. Knockdown of HuR reduces ARID1A levels, increases reactive oxygen species (ROS), and sensitizes cells to radiation by impairing DNA repair. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/jhixrx1.
Figure 6 DNA double-strand break (DSB) repair mechanisms and their role in radiation resistance. (A) DSBs can be repaired through homologous recombination (HR) when a sister chromatid is available as a template, typically during the S and G2 phases of the cell cycle [52]. Alternatively, non-homologous end joining (NHEJ) directly ligates the broken DNA ends without a homologous template [52]. (B) Denticleless E3 ubiquitin protein ligase homolog (DTL) ubiquitinates RuvB-like AAA ATPase 1 (RUVBL1) to facilitate the formation of the RUVBL1/2–β-catenin complex, which transcriptionally upregulates genes involved in the NHEJ pathway, thereby enhancing DNA repair and promoting radiation resistance (C) Human antigen R (HuR), an RNA-binding protein often overexpressed in breast cancer, stabilizes AT-rich interaction domain 1A (ARID1A) mRNA, leading to increased ARID1A expression and enhanced DSB repair [39]. Knockdown of HuR reduces ARID1A levels, increases reactive oxygen species (ROS), and sensitizes cells to radiation by impairing DNA repair. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/jhixrx1.CC BY · PubMed Central
Figure 7 Growth factor–activated signaling pathways and their downstream targets contributing to radiation resistance in breast cancer. Summary of important signaling pathways for cancer progression and some of their downstream effects. The binding of growth factors (GF) such as EGF, PDGF, IGF, HGF, etc., to their respective ligand receptors triggers an effect throughout the PI3K/Akt/mTOR, Jak/STAT, and MAPK/ERK signaling pathways [78]. These pathways influence cancer progression and radiation resistance by influencing the regulation and activity of a variety of proteins which in turn influence factors such as apoptosis evasion, proliferation and angiogenesis [105,106,107]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/lui2zt2.
Figure 7 Growth factor–activated signaling pathways and their downstream targets contributing to radiation resistance in breast cancer. Summary of important signaling pathways for cancer progression and some of their downstream effects. The binding of growth factors (GF) such as EGF, PDGF, IGF, HGF, etc., to their respective ligand receptors triggers an effect throughout the PI3K/Akt/mTOR, Jak/STAT, and MAPK/ERK signaling pathways [78]. These pathways influence cancer progression and radiation resistance by influencing the regulation and activity of a variety of proteins which in turn influence factors such as apoptosis evasion, proliferation and angiogenesis [105,106,107]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/lui2zt2.CC BY · PubMed Central
Figure 9 Nanoparticle-based strategies to overcome hypoxia-driven radiation resistance in breast cancer. (A) The outermost portion of a tumor is typically vascularized and well oxygenated, while the deeper portions of the tumor are less oxygenated [117]. Gold nanoparticles can increase the radiosensitivity of the cancerous cells although their effectiveness relies on the formation of ROS, so extreme hypoxia negates the change in radiosensitivity caused by the gold nanoparticles [117]. (B) Breast cancer when treated with gold nanoparticles loaded with thiolate cupferron, near-infrared treatment and ionizing radiation results in the formation of nitric oxide (NO), ROS, and reactive nitrogen species (RNS) causing cell death [118]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/e9c8tmv.
Figure 9 Nanoparticle-based strategies to overcome hypoxia-driven radiation resistance in breast cancer. (A) The outermost portion of a tumor is typically vascularized and well oxygenated, while the deeper portions of the tumor are less oxygenated [117]. Gold nanoparticles can increase the radiosensitivity of the cancerous cells although their effectiveness relies on the formation of ROS, so extreme hypoxia negates the change in radiosensitivity caused by the gold nanoparticles [117]. (B) Breast cancer when treated with gold nanoparticles loaded with thiolate cupferron, near-infrared treatment and ionizing radiation results in the formation of nitric oxide (NO), ROS, and reactive nitrogen species (RNS) causing cell death [118]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/e9c8tmv.CC BY · PubMed Central
Figure 1 Histological subtypes of breast cancer. Illustration of four common histological subtypes of breast cancer: ductal, lobular, mucinous, and inflammatory. Ductal and lobular carcinomas originate from the milk ducts and lobules, respectively. Mucinous carcinoma is characterized by tumor cells suspended in mucin pools, while inflammatory breast cancer presents with dermal lymphatic invasion, causing erythema and edema. Created with BioRender. Mageau, E. (2025) https://BioRender.com/vp8dakl.
Figure 1 Histological subtypes of breast cancer. Illustration of four common histological subtypes of breast cancer: ductal, lobular, mucinous, and inflammatory. Ductal and lobular carcinomas originate from the milk ducts and lobules, respectively. Mucinous carcinoma is characterized by tumor cells suspended in mucin pools, while inflammatory breast cancer presents with dermal lymphatic invasion, causing erythema and edema. Created with BioRender. Mageau, E. (2025) https://BioRender.com/vp8dakl.CC BY · PubMed Central
Figure 2 Mechanisms of radiation-induced DNA damage: direct and indirect effects. Ionizing radiation damages DNA through two primary mechanisms. In direct damage, radiation interacts directly with DNA molecules, causing strand breaks and base modifications. In indirect damage, radiation interacts with cellular water to generate reactive oxygen species (ROS), which then chemically damage DNA. Both pathways contribute to the cytotoxic effects of radiation therapy. Created in BioRender. Derbowka, R. (2025) https://BioRender.com/49mv0nd.
Figure 2 Mechanisms of radiation-induced DNA damage: direct and indirect effects. Ionizing radiation damages DNA through two primary mechanisms. In direct damage, radiation interacts directly with DNA molecules, causing strand breaks and base modifications. In indirect damage, radiation interacts with cellular water to generate reactive oxygen species (ROS), which then chemically damage DNA. Both pathways contribute to the cytotoxic effects of radiation therapy. Created in BioRender. Derbowka, R. (2025) https://BioRender.com/49mv0nd.CC BY · PubMed Central
Figure 3 PRISMA-based flow diagram of study selection for systematic review. Summary of the identification, screening, and inclusion process for studies selected in this systematic review. A total of 135 articles were identified through PubMed using the search terms “breast cancer” AND “radiation resistance.” After applying exclusion criteria—reviews, pre-2002 publications, non-mammalian models, non-breast cancers, and studies lacking specific molecular targets—79 articles remained for inclusion. Created in BioRender. Mageau, E. (2025) https://BioRender.com/zgehzac.
Figure 3 PRISMA-based flow diagram of study selection for systematic review. Summary of the identification, screening, and inclusion process for studies selected in this systematic review. A total of 135 articles were identified through PubMed using the search terms “breast cancer” AND “radiation resistance.” After applying exclusion criteria—reviews, pre-2002 publications, non-mammalian models, non-breast cancers, and studies lacking specific molecular targets—79 articles remained for inclusion. Created in BioRender. Mageau, E. (2025) https://BioRender.com/zgehzac.CC BY · PubMed Central
Figure 4 Key molecular pathways activated in CD44+/CD24−/low breast cancer stem cells contributing to radiation resistance. Schematic representation of molecular targets and signaling pathways associated with radiation resistance in breast cancer stem cells exhibiting the CD44+/CD24−/low phenotype. CD44-mediated signaling has been linked to the upregulation of ALDH1, IFIT2, ATM, and the mTOR pathway, including its downstream effector phosphorylated S6 kinase 1 (p-S6K1). These factors contribute to enhanced DNA repair capacity, survival, and resistance to radiotherapy. The tumor microenvironment further enhances these characteristics in breast cancer through the secretion of interleukin-6 (IL-6) and platelet-derived growth factors from cancer-associated fibroblasts. Tumor-associated macrophages further contribute to therapy resistance through the secretion of interleukin-10 (IL-10). Created in BioRender. Mageau, E. (2025) https://BioRender.com/c6b46ka.
Figure 4 Key molecular pathways activated in CD44+/CD24−/low breast cancer stem cells contributing to radiation resistance. Schematic representation of molecular targets and signaling pathways associated with radiation resistance in breast cancer stem cells exhibiting the CD44+/CD24−/low phenotype. CD44-mediated signaling has been linked to the upregulation of ALDH1, IFIT2, ATM, and the mTOR pathway, including its downstream effector phosphorylated S6 kinase 1 (p-S6K1). These factors contribute to enhanced DNA repair capacity, survival, and resistance to radiotherapy. The tumor microenvironment further enhances these characteristics in breast cancer through the secretion of interleukin-6 (IL-6) and platelet-derived growth factors from cancer-associated fibroblasts. Tumor-associated macrophages further contribute to therapy resistance through the secretion of interleukin-10 (IL-10). Created in BioRender. Mageau, E. (2025) https://BioRender.com/c6b46ka.CC BY · PubMed Central
Figure 5 Regulation of FEN1 by YY1 and its impact on radiation sensitivity in breast cancer cells. This figure illustrates the proposed mechanism by which the transcription factor YY1 regulates FEN1 expression and influences DNA repair capacity and radiation response. In normal breast cancer cells, YY1 binds to the FEN1 promoter and suppresses its expression, resulting in reduced DNA repair activity and increased radiation sensitivity. In contrast, radiation-resistant breast cancer cells exhibit reduced YY1 expression, leading to upregulation of FEN1, enhanced DNA repair, and increased radiation resistance. Created in BioRender. Mageau, E. (2025) https://BioRender.com/vtbz5js.
Figure 5 Regulation of FEN1 by YY1 and its impact on radiation sensitivity in breast cancer cells. This figure illustrates the proposed mechanism by which the transcription factor YY1 regulates FEN1 expression and influences DNA repair capacity and radiation response. In normal breast cancer cells, YY1 binds to the FEN1 promoter and suppresses its expression, resulting in reduced DNA repair activity and increased radiation sensitivity. In contrast, radiation-resistant breast cancer cells exhibit reduced YY1 expression, leading to upregulation of FEN1, enhanced DNA repair, and increased radiation resistance. Created in BioRender. Mageau, E. (2025) https://BioRender.com/vtbz5js.CC BY · PubMed Central
Figure 8 Differential expression of key miRNAs in radiation-sensitive and radiation-resistant breast cancer cells. This figure illustrates the contrasting expression profiles of miRNAs in radiation-sensitive versus radiation-resistant breast cancer cells following ionizing radiation. In radiation-sensitive cells, high miR-634 expression suppresses STAT3, leading to increased rates of apoptosis and DDR. In contrast, lower levels of miR-33a allows for higher expression of ABCA1, facilitating membrane cholesterol efflux via HDL and increasing radiosensitivity. In contrast, radiation-resistant cells exhibit higher levels of miR-33a, leading to higher radiation resistance. miR-144 and miR-21 are both involved in downregulation of PTEN, leading to increased AKT signaling and resulting in increased radiation resistance. Red arrows and text indicates downregulation. Created in BioRender. Derbowka, R. (2025) https://BioRender.com/ricemzw.
Figure 8 Differential expression of key miRNAs in radiation-sensitive and radiation-resistant breast cancer cells. This figure illustrates the contrasting expression profiles of miRNAs in radiation-sensitive versus radiation-resistant breast cancer cells following ionizing radiation. In radiation-sensitive cells, high miR-634 expression suppresses STAT3, leading to increased rates of apoptosis and DDR. In contrast, lower levels of miR-33a allows for higher expression of ABCA1, facilitating membrane cholesterol efflux via HDL and increasing radiosensitivity. In contrast, radiation-resistant cells exhibit higher levels of miR-33a, leading to higher radiation resistance. miR-144 and miR-21 are both involved in downregulation of PTEN, leading to increased AKT signaling and resulting in increased radiation resistance. Red arrows and text indicates downregulation. Created in BioRender. Derbowka, R. (2025) https://BioRender.com/ricemzw.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 131 references

Cited by

See all 13

Metadata

Authors
Mageau, E., Derbowka, R., Dickinson, N., Lefort, N., Kovala, A. T., Boreham, D. R., Tai, T. C., Thome, C., & Tharmalingam, S.
Affiliations
  • Laurentian University (CA)
  • NOSM University (CA)
  • Health Sciences North (CA)
Corresponding author
Tharmalingam, Sujeenthar
Venue
Current Issues in Molecular Biology
Publisher
MDPI AG
Published
2025-07-24
Volume
47
Issue
8
Pages
589
ISSN
  • 1467-3037 (ISSN-L)
  • 1467-3045
OpenAlex
W4412628978
Cited by
12
References
136
Citations by year
2026: 8 · 2025: 4
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Current Issues in Molecular Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NSERC Discovery Grant
  • Northern Cancer Foundation
  • Northern Ontario School of Medicine University Faculty Association Research Development Award
  • Canada Graduate Scholarships—Master’s program
  • Ontario Graduate Scholarship
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
breast cancer, radioresistance (biology), radiosensitization, PI3K/AKT/mTOR pathway, MAPK signaling, DNA repair, non-homologous end joining, cancer stem cells, CD44, ALDH1, non-coding RNA, DUXAP8, microRNA, miR-21, tumor microenvironment, cancer-associated fibroblasts, immune regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies. https://app.cochat.ai/papers/10.3390/cimb47080589
The paper
Mageau, E., Derbowka, R., Dickinson, N., Lefort, N., Kovala, A. T., Boreham, D. R., Tai, T. C., Thome, C., & Tharmalingam, S. (2025). Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies. Current Issues in Molecular Biology. https://doi.org/10.3390/cimb47080589

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.